Table 3 Results of questionnaires at baseline. Results are mean (standard deviation)
From: Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
Questionnaires, all mean (SD) | Â |
|---|---|
 KCCQ physical limitation score | 89 (16) |
 KCCQ symptom stability score | 51 (10) |
 KCCQ symptom burden score | 92 (14) |
 KCCQ self-efficacy score | 85 (23) |
 KCCQ quality of life score | 87 (20) |
 KCCQ social limitation score | 92 (17) |
 KCCQ total symptom score | 92 (14) |
 KCCQ clinical summary score | 91 (14) |
 KCCQ overall summary score | 90 (15) |
 PASE score | 155 (90) |